Pfizer To Combat Declining Sales of Viagra With Over-the-Counter Launch

Photo by pichumani from Flickr

For the first time in the United Kingdom, Viagra about to become available over the counter as Pfizer, its manufacturer wrestles with the declining sales of the said drug.

The US giant hopes that the coming release of its over-the-counter product that will be called Viagra Connect will help in making up for dwindling sales of prescription Viagra amidst the competition from its copycat rivals.

Global sales were at $1.2bn (£850m) in 2017, down by nearly half on $2.1bn five years earlier.

The Viagra Connect product could also prove to be an asset for the consumer healthcare division of Pfizer, which it has been striving to sell after both Reckitt Benckiser and GSK withdrew from the $20bn contest to acquire the said division last week.

Pfizer estimates that more than a fifth of adult males in the United Kingdom who are over 18 years of age are suffering from erectile dysfunction. However, only a few seek treatment.

The general manager for the UK consumer healthcare division of Pfizer, Paul Rose, said: “There’s a clear unmet need.”

Pfizer has been training numerous pharmacists on how to best consult people who are interested in purchasing Viagra Connect, which will be available in 14,000 stores across the United Kingdom and via the websites of various pharmacies.